Navigation auf


Epidemiology, Biostatistics and Prevention Institute

Julian D. Maier

Julian D. Maier, Dr. med.

  • Resident Physician


  • Tafenoquine for malaria chemoprophylaxis - Status quo 2022, DOI: 10.1016/j.tmaid.2022.102268 
  • Bacterial but no SARS-CoV-2 contamination after terminal disinfection of tertiary care intensive care units treating COVID-19 patients, DOI: 10.1186/s13756-021-00885-z
  • Efficacy and safety of tafenoquine for malaria chemoprophylaxis (1998-2020): A systematic review and meta-analysis, DOI: 10.1016/j.tmaid.2020.101908
  • Repurposing antimalarials and other drugs for COVID-19, DOI: 10.1016/j.tmaid.2020.101658
  • Antiviral potential of 3′-sialyllactose- and 6′-sialyllactose-conjugated dendritic polymers against human and avian influenza viruses, DOI: 10.1038/s41598-020-57608-4